|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1997-10-21
|
|
pubmed:abstractText |
To evaluate the efficacy and complications of intracameral recombinant tissue plasminogen activator (r-tPA) in the treatment of severe fibrinous effusion after cataract and combined cataract and glaucoma surgery.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0886-3350
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
23
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
873-7
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9292671-Aged,
pubmed-meshheading:9292671-Anterior Chamber,
pubmed-meshheading:9292671-Female,
pubmed-meshheading:9292671-Fibrinolysis,
pubmed-meshheading:9292671-Follow-Up Studies,
pubmed-meshheading:9292671-Glaucoma,
pubmed-meshheading:9292671-Humans,
pubmed-meshheading:9292671-Lenses, Intraocular,
pubmed-meshheading:9292671-Male,
pubmed-meshheading:9292671-Phacoemulsification,
pubmed-meshheading:9292671-Plasminogen Activators,
pubmed-meshheading:9292671-Postoperative Complications,
pubmed-meshheading:9292671-Prospective Studies,
pubmed-meshheading:9292671-Recombinant Proteins,
pubmed-meshheading:9292671-Thrombolytic Therapy,
pubmed-meshheading:9292671-Tissue Plasminogen Activator,
pubmed-meshheading:9292671-Trabeculectomy,
pubmed-meshheading:9292671-Treatment Outcome
|
|
pubmed:articleTitle |
Intracameral tissue plasminogen activator to treat severe fibrinous effusion after cataract surgery.
|
|
pubmed:affiliation |
University Eye Hospital Vienna, Austria.
|
|
pubmed:publicationType |
Journal Article
|
